Literature DB >> 20340043

Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading.

Andrew D Cox1, Frank St Michael, Dhamodharan Neelamegan, Suzanne Lacelle, Chantelle Cairns, James C Richards.   

Abstract

In previous studies protective antibodies that could facilitate bactericidal killing of Neisseria meningitidis (Nm) serogroup B strains were derived from immunisation with glycoconjugates prepared from O-deacylated lipopolysaccharide (LPS-OH) via direct reductive amination between the reducing end of the oligosaccharide molecule, created by treatment with alkaline phosphatase, and amino functionalities on the CRM(197) carrier protein. These glycoconjugates proved difficult to prepare because the presence of amide linked fatty-acyl groups results in glycolipids that are relatively insoluble and aggregate. Therefore, we have examined several strategies to prepare glycoconjugates in order to identify a robust, consistently reproducible strategy that produces glycoconjugates with a high loading of LPS derived oligosaccharides. Initially we used completely deacylated LPS molecules, but lacking phosphoethanolamine (PEtn) from the core OS as the strong basic conditions required to completely deacylate the LPS would modify the PEtn residue. We utilised a squarate linker and conjugated via the reducing end of the carbohydrate antigen following removal of the glycosidic phosphate to amino groups on CRM(197), however carbohydrate loading on the carrier protein was low. Glycoconjugates were then produced utilising amidases produced by Dictyostelium discoideum (Dd), which partially remove N-linked fatty acids from the lipid A region of the Nm LPS molecule, which enabled the retention of the PEtn residue. LPS-OH was treated with Dd amidase, the reducing glycosidic phosphate removed, and using a cystamine linker strategy, conjugated to the carrier protein. Carbohydrate loading was somewhat improved but still not high. Finally, we have developed a novel conjugation strategy that targets the amino functionality created by the amidase activity as the attachment point. The amino functionality on the PEtn residue of the inner core was protected via a novel blocking and unblocking strategy with t-butyl oxycarbonyl. A maleimide-thiol linker strategy, targeting lysine residues on the carrier protein did not result in high loading of the carbohydrate molecules, however when we targeted the carboxyl residues we have consistently obtained a high loading of carbohydrate antigens per CRM(197), which can be controlled by variation in the amount of activated carbohydrate utilised in the conjugation reaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20340043     DOI: 10.1007/s10719-010-9287-0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  22 in total

1.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.

Authors:  Yanwen Li; Yao-hui Sun; Cathy Ison; Myron M Levine; Christoph M Tang
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

4.  The structure of lipopolysaccharide from an Escherichia coli heptose-less mutant. III. Two fatty acyl amidases from Dictyostelium discoideum and their action on lipopolysaccharide derivatives.

Authors:  M R Rosner; R C Verret; H G Khorana
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis.

Authors:  Fiona G Mackinnon; Andrew D Cox; Joyce S Plested; Christoph M Tang; Katherine Makepeace; Philip A Coull; J Claire Wright; Ronald Chalmers; Derek W Hood; James C Richards; E Richard Moxon
Journal:  Mol Microbiol       Date:  2002-02       Impact factor: 3.501

7.  MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.

Authors:  Philipp Oster; Diana Lennon; Jane O'Hallahan; Kim Mulholland; Stewart Reid; Diana Martin
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

8.  Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.

Authors:  Joyce S Plested; Shannon L Harris; J Claire Wright; Philip A Coull; Katherine Makepeace; Margaret-Anne J Gidney; Jean-Robert Brisson; James C Richards; Dan M Granoff; E Richard Moxon
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.

Authors:  Anne Jäkel; Joyce S Plested; J Claire Hoe; Katherine Makepeace; Margaret-Anne J Gidney; Suzanne Lacelle; Frank St Michael; Andrew D Cox; James C Richards; E Richard Moxon
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

View more
  7 in total

1.  Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.

Authors:  Andrew D Cox; Frank St Michael; Dhamodharan Neelamegan; Suzanne Lacelle; Chantelle M Cairns; Marzia M Giuliani; Alessia Biolchi; J Claire Hoe; E Richard Moxon; James C Richards
Journal:  Glycoconj J       Date:  2010-10-05       Impact factor: 2.916

2.  Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.

Authors:  F St Michael; C M Cairns; A L Filion; A Biolchi; B Brunelli; M Giuliani; J C Richards; A D Cox
Journal:  Glycoconj J       Date:  2013-09-07       Impact factor: 2.916

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica.

Authors:  Frank St Michael; Chantelle Cairns; Amy Lea Filion; Dhamodharan Neelamegan; Suzanne Lacelle; Andrew D Cox
Journal:  Glycoconj J       Date:  2011-06-24       Impact factor: 2.916

5.  Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.

Authors:  Andrew D Cox; Frank St Michael; Chantelle M Cairns; Suzanne Lacelle; Amy Lea Filion; Dhamodharan Neelamegan; Cory Q Wenzel; Heather Horan; James C Richards
Journal:  Glycoconj J       Date:  2011-05-18       Impact factor: 2.916

6.  Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Authors:  Eli B Nix; Kylie Williams; Andrew D Cox; Frank St Michael; Sandra Romero-Steiner; Daniel S Schmidt; William G McCready; Marina Ulanova
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

Review 7.  Meningococcal Vaccines: Current Status and Emerging Strategies.

Authors:  Pumtiwitt C McCarthy; Abeer Sharyan; Laleh Sheikhi Moghaddam
Journal:  Vaccines (Basel)       Date:  2018-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.